Enrolling by invitationNCT04989751
A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China
Studying Calpain-3-related limb-girdle muscular dystrophy R1
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Huashan Hospital
- Principal Investigator
- Chongbo Zhao, PhDHuashan Hospital
- Intervention
- Electromyography(diagnostic_test)
- Enrollment
- 450 enrolled
- Eligibility
- 10 years · All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Huashan Hospital, Shanghai, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04989751 on ClinicalTrials.govOther trials for Calpain-3-related limb-girdle muscular dystrophy R1
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT05618080LGMD R1 Natural History StudyVirginia Commonwealth University
- RECRUITINGPHASE1, PHASE2NCT05230459A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)AskBio Inc
See all trials for Calpain-3-related limb-girdle muscular dystrophy R1 →